Literature DB >> 2918943

Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay.

M Bingel1, W Arndt, M Schulze, J Floege, S Shaldon, K M Koch, O Götze.   

Abstract

Using a specific and sensitive ELISA for C5a, the present study shows that predialysis levels of C5a in end-stage renal disease patients are not elevated and that all membranes studied (Cuprophan, Hemophan, Gambrane and hydrophilic polysulfone) cause significant increases of C5a plasma levels albeit to different degrees. Higher increases of C5a were accompanied by larger decreases of circulating granulocytes and monocytes. Dialyzers with a newly introduced modified regenerated cellulose membrane, Hemophan, showed lower C5a plasma levels during hemodialysis than Cuprophan. With Hemophan C5a plasma levels were comparable to those with polysulfone membranes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918943     DOI: 10.1159/000185316

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.

Authors:  A Y Annenkov; A G Strokov; F S Baranova
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Neutrophil dysfunction in end-stage renal failure: reduced response to priming by C5a.

Authors:  G J Dobos; A E Traynor-Kaplan; D Ward; P J Schollmeyer
Journal:  Clin Investig       Date:  1994-05

3.  Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.

Authors:  M Oppermann; O Götze
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

4.  Stimulation of neutrophil functions by C5a(desArg): an in vitro model of haemodialysis.

Authors:  I Eckle; G Kolb; E M Martin; K Havemann
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.